Why is confirmatory, genetic testing mandatory for helping clinicians identify therapeutic agents that are best suited for an individual patient? And to determine whether a mutation is amenable to chaperone therapy?

Why is confirmatory, genetic testing mandatory for helping clinicians identify therapeutic agents that are best suited for an individual patient? And to determine whether a mutation is amenable to chaperone therapy?

Why is confirmatory, genetic testing mandatory for helping clinicians identify therapeutic agents that are best suited for an individual patient? And to determine whether a mutation is amenable to chaperone therapy?


Created by

CMEducation Resources IQ&A Fabry Disease Diagnostic Intelligence Zone

Presenter

Heather Lau, MD

Heather Lau, MD

Assistant Professor, Department of Neurology
Associate Director, Division of Neurogenetics
Director, Lysosomal Storage Disease Program
NYU Langone
New York, NY